EUVIMEDEUVIMED entdecken
Crossref

Ethanol Ablation for Benign Insulinoma: Intraoperative and Endoscopic Approaches

Alaa Sada, Dhanya Ramachandran, Meher Oberoi, Elizabeth B Habermann, Melanie L Lyden, Benzon M Dy, Trenton R Foster, Thorvardur R Halfdanarson, Michael J Levy, Adrian Vella, Travis J McKenzie

Journal of Surgical Research · 2024

DOI: 10.1016/j.jss.2023.08.018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Research, 2024. Verfasst von Alaa Sada und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Mayo Clinic, Rochester, Minnesota. Hauptthemen laut MEDLINE: Insulinoma, Pancreatic Neoplasms, Hypoglycemia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Ethanol ablation can be utilized to manage insulinoma. We aimed to analyze our outcomes of endoscopic ultrasound (EUS) and intraoperative ultrasound (IOUS) guided Ethanol ablation of insulinoma. METHODS: A single institution retrospective review of adults undergoing Ethanol ablation of benign pancreatic insulinoma (2007-2022) was performed. Outcomes were categorized as resolution of hypoglycemia, improvement, or no change at last follow-up. RESULTS: A total of 16 patients underwent Ethanol ablation of benign insulinoma (N = 8 EUS, N = 8 IOUS): median age was 68 y, 8 (50%) were females, and 2 (12.5%) were associated with multiple endocrine neoplasia type-1. Median insulinoma size was 12 (range 7, 25) mm. Ethanol ablation was preferred over resection to avoid pancreaticoduodenectomy when it was not possible to enucleate the tumor in 10 (62.5%) patients while the rest underwent ablation due to being poor surgical candidates or because of a history of previous pancreatic resection. The median follow-up (interquartile range) was 43 (19.5, 81.5) mo. Resolution of hypoglycemia occurred in 11 patients (5 EUS, 6 IOUS), while the rest (3 EUS, 2 IOUS) experienced improvement in the severity and frequency of hypoglycemia. A single patient underwent resection following a previous ablation for symptomatic hypoglycemia 5 y after EUS guided ablation. CONCLUSIONS: Ethanol ablation provides an alternative therapeutic option for patients with insulinoma. Both EUS and IOUS guided approaches are associated with a favorable resolution rate although EUS guided ablation may require multiple procedures to optimize outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InsulinomaPancreatic NeoplasmsHypoglycemiaAdultFemaleHumansAgedMaleEthanolUltrasonographyEndosonography

Stichwörter der Autor:innen

AblationAlcoholEthanolInsulinoma

Substanzen

Ethanol

Autor:innen und Institutionen

  • Department of Surgery, Mayo Clinic, Rochester, Minnesota.
  • Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota.
  • Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota.
  • Division of Gastroenterology, Mayo Clinic, Rochester, Minnesota.
  • Division of Endocrinology, Mayo Clinic, Rochester, Minnesota.
  • Department of Surgery, Mayo Clinic, Rochester, Minnesota. Electronic address: Mckenzie.Travis@mayo.edu.

Zitieren

APA

Sada, A., Ramachandran, D., Oberoi, M., Habermann, E. B., Lyden, M. L., Dy, B. M., Foster, T. R., Halfdanarson, T. R., Levy, M. J., Vella, A., & McKenzie, T. J. (2024). Ethanol Ablation for Benign Insulinoma: Intraoperative and Endoscopic Approaches. Journal of Surgical Research. https://doi.org/10.1016/j.jss.2023.08.018

Vancouver

Sada A, Ramachandran D, Oberoi M, Habermann EB, Lyden ML, Dy BM, et al. Ethanol Ablation for Benign Insulinoma: Intraoperative and Endoscopic Approaches. Journal of Surgical Research. 2024. doi:10.1016/j.jss.2023.08.018

BibTeX
@article{Sada2024,
  author = {Sada, Alaa and Ramachandran, Dhanya and Oberoi, Meher and Habermann, Elizabeth B and Lyden, Melanie L and Dy, Benzon M and Foster, Trenton R and Halfdanarson, Thorvardur R and Levy, Michael J and Vella, Adrian and McKenzie, Travis J},
  title = {Ethanol Ablation for Benign Insulinoma: Intraoperative and Endoscopic Approaches},
  journal = {Journal of Surgical Research},
  year = {2024},
  doi = {10.1016/j.jss.2023.08.018}
}
Kostenlos starten →